Nguyen DX, Bos PD, Massagué J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009, 9: 274-84. 10.1038/nrc2622.
Article
CAS
PubMed
Google Scholar
Pantel K, Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer. 2004, 4: 448-56. 10.1038/nrc1370.
Article
CAS
PubMed
Google Scholar
Klein CA: Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009, 9: 302-12. 10.1038/nrc2627.
Article
CAS
PubMed
Google Scholar
Aguirre-Ghiso Julio: Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007, 7: 834-46. 10.1038/nrc2256.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pantel K, Alix-Panabières C, Riethdorf S: Cancer micrometastases. Nat Rev Clin Oncol. 2009, 6: 339-51. 10.1038/nrclinonc.2009.44.
Article
CAS
PubMed
Google Scholar
Ashworth TR: A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J. 1869, 14: 146-149.
Google Scholar
Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A, Pantel K: A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005, 353: 793-802. 10.1056/NEJMoa050434.
Article
CAS
PubMed
Google Scholar
Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis Ch, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D, Georgoulias V: Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol. 2002, 20: 3404-12. 10.1200/JCO.2002.08.135.
Article
CAS
PubMed
Google Scholar
Xenidis N, Vlachonikolis I, Mavroudis D, Perraki M, Stathopoulou A, Malamos N, Kouroussis C, Kakolyris S, Apostolaki S, Vardakis N, Lianidou E, Georgoulias V: Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. Ann Oncol. 2003, 14: 849-55. 10.1093/annonc/mdg259.
Article
CAS
PubMed
Google Scholar
Xenidis N, Perraki M, Kafousi M, Apostolaki S, Bolonaki I, Stathopoulou A, Kalbakis K, Androulakis N, Kouroussis C, Pallis T, Christophylakis C, Argyraki K, Lianidou ES, Stathopoulos S, Georgoulias V, Mavroudis D: Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol. 2006, 24: 3756-62. 10.1200/JCO.2005.04.5948.
Article
CAS
PubMed
Google Scholar
Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias V, Mavroudis D: Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res. 2008, 14: 2593-600. 10.1158/1078-0432.CCR-07-4758.
Article
CAS
PubMed
Google Scholar
Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D: Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. J Clin Oncol. 2007, 25: 5194-202. 10.1200/JCO.2007.11.7762.
Article
PubMed
Google Scholar
Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW: Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005, 23: 1420-30. 10.1200/JCO.2005.08.140.
Article
PubMed
Google Scholar
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004, 351: 781-91. 10.1056/NEJMoa040766.
Article
CAS
PubMed
Google Scholar
Xenidis N, Ignatiadis M, Apostolaki S, Perraki M, Kalbakis K, Agelaki S, Stathopoulos EN, Chlouverakis G, Lianidou E, Kakolyris S, Georgoulias V, Mavroudis D: Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J Clin Oncol. 2009, 27: 2177-84. 10.1200/JCO.2008.18.0497.
Article
CAS
PubMed
Google Scholar
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008, 14: 6302-9. 10.1158/1078-0432.CCR-08-0872.
Article
CAS
PubMed
Google Scholar
Ignatiadis M, Georgoulias V, Mavroudis D: Circulating tumor cells in breast cancer. Curr Opin Obstet Gynecol. 2008, 20: 55-60. 10.1097/GCO.0b013e3282f22b2e.
Article
PubMed
Google Scholar
Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D, Heller G: Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol. 2009, 10: 233-9. 10.1016/S1470-2045(08)70340-1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, Morrison L, Herlyn D, Terstappen LW, Fleming T, Fehm T, Tucker T, Lane N, Wang J, Uhr J: HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci USA. 2004, 101: 9393-8. 10.1073/pnas.0402993101.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bozionellou V, Mavroudis D, Perraki M, Papadopoulos S, Apostolaki S, Stathopoulos E, Stathopoulou A, Lianidou E, Georgoulias V: Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer. Clin Cancer Res. 2004, 10: 8185-94. 10.1158/1078-0432.CCR-03-0094.
Article
CAS
PubMed
Google Scholar
Müller V, Pantel K: HER2 as marker for the detection of circulating tumor cells. Breast Cancer Res Treat. 2009, 117: 535-7. 10.1007/s10549-008-0276-y.
Article
PubMed
Google Scholar
Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ: Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res. 2006, 12: 5615-21. 10.1158/1078-0432.CCR-06-0169.
Article
CAS
PubMed
Google Scholar
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S: Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009, 11: R46-10.1186/bcr2333.
Article
PubMed
PubMed Central
Google Scholar
Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, Pantel K, Solomayer E: A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer. 2006, 107: 885-92. 10.1002/cncr.22076.
Article
PubMed
Google Scholar
Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M: Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer. 2005, 92: 906-12. 10.1038/sj.bjc.6602418.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL: Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res. 2005, 11: 3722-32. 10.1158/1078-0432.CCR-04-1483.
Article
CAS
PubMed
Google Scholar
Hartmann CH, Klein CA: Gene expression profiling of single cells on large-scale oligonucleotide arrays. Nucleic Acids Res. 2006, 34: e143-10.1093/nar/gkl740.
Article
PubMed
PubMed Central
Google Scholar
Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES: Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin Cancer Res. 2003, 9: 5145-51.
CAS
PubMed
Google Scholar
Stathopoulou A, Ntoulia M, Perraki M, Apostolaki S, Mavroudis D, Malamos N, Georgoulias V, Lianidou ES: A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer. Int J Cancer. 2006, 119: 1654-9. 10.1002/ijc.22017.
Article
CAS
PubMed
Google Scholar
Sieuwerts AM, Kraan CJ, Bolt-de Vries J, van der Spoel P, Mostert B, Martens JW, Gratama J, Sleijfer S, Foekens JA: Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat. 2009, 118: 455-468. 10.1007/s10549-008-0290-0.
Article
CAS
PubMed
Google Scholar
Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K: Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 2007, 13: 920-8. 10.1158/1078-0432.CCR-06-1695.
Article
CAS
PubMed
Google Scholar
Kallergi G, Markomanolaki H, Giannoukaraki V, Papadaki MA, Strati A, Lianidou ES, Georgoulias V, Mavroudis D, Agelaki S: Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res. 2009, 11: R84-10.1186/bcr2452.
Article
PubMed
PubMed Central
Google Scholar
Zheng S, Lin H, Liu JQ, Balic M, Datar R, Cote RJ, Tai YC: Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A. 2007, 1162: 154-61. 10.1016/j.chroma.2007.05.064.
Article
CAS
PubMed
Google Scholar
Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M: Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007, 450: 1235-9. 10.1038/nature06385.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wittwer CT, Herrmann MG, Gundry CN, Elenitoba-Johnson KS: Real-time multiplex PCR assays. Methods. 2001, 25: 430-42. 10.1006/meth.2001.1265.
Article
CAS
PubMed
Google Scholar
Mavrogiannou E, Strati A, Stathopoulou A, Tsaroucha EG, Kaklamanis L, Lianidou ES: Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer. Clin Chem. 2007, 53: 53-61.
Article
CAS
PubMed
Google Scholar
Ntoulia M, Stathopoulou A, Ignatiadis M, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES: Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR. Clin Biochem. 2006, 39: 879-87. 10.1016/j.clinbiochem.2006.06.009.
Article
CAS
PubMed
Google Scholar
Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. 1989, Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY, 2
Google Scholar
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer : The MIQE Guidelines Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clin Chem. 2009, 55: 611-622. 10.1373/clinchem.2008.112797.
Article
CAS
PubMed
Google Scholar
Korkaya H, Wicha MS: HER-2, notch, and breast cancer stem cells: targeting an axis of evil. Clin Cancer Res. 2009, 15: 1845-7. 10.1158/1078-0432.CCR-08-3087.
Article
CAS
PubMed
Google Scholar
Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, Yeh RF, Pirzkall A, Fine BM, Lukas C, Amler LC, Chen DS, Lackner MR: Molecular Biomarker Analyses Using Circulating Tumor Cells. PLoS ONE. 2010, 5: e12517-10.1371/journal.pone.0012517.
Article
PubMed
PubMed Central
Google Scholar
Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS: Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res. 2001, 61: 8845-50.
CAS
PubMed
Google Scholar
Mego M, Mani SA, Lee BN, Li C, Evans KW, Cohen EN, Gao H, Jackson SA, Giordano A, Hortobagyi GN, Cristofanilli M, Lucci A, Reuben JM: Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy. Int J Cancer. 2011.
Google Scholar